UnknownPhase 1ketamine

Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine

NCT ID

NCT00520104

Target Enrollment

48 participants

Start Date

2007-08

Est. Completion

2008-03

About This Study

This is an open label, single-center study to determine whether certain nasal medication interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients with allergic rhinitis.

Conditions Studied

Pharmacokinetics

Interventions

•intranasal ketamine

Eligibility

Age:18 Years - N/A

Healthy Volunteers:Yes

View full eligibility criteria

Inclusion Criteria:

* Healthy adults
* Patients with Allergic Rhinitis

Exclusion Criteria:

* Under age 18

Study Locations (1)

Javelin Pharmaceuticals

Cambridge, Massachusetts, United States